Fig. S1. GRIM-19 protein expression in U251MG and U87MG malignant glioma cells transfected with various vectors.

Fig. S2. Effect of GRIM-19 on STAT3 nuclear translocation in malignant glioma cells using double immunofluorescence staining.

Fig. S3. Expression of STAT3-dependent genes in U251MG malignant glioma cells with different treatments using RT-PCR.

Fig. S4. Expression of STAT3 target genes in U251MG malignant glioma cells with different treatments. Induction of endogenous GRIM-19 reduced interleukin (IL)-6-stimulated STAT3 nuclear translocation

Fig. S5. Expression of two STAT3-independent genes in U251MG malignant glioma cells following different treatments.

Table S1. Primers used for RT-PCR analysis.

Table S2. GRIM-19 protein expression in glioma samples.

CAS_2059_sm_FigS1.tif2076KSupporting info item
CAS_2059_sm_FigS2.tif2643KSupporting info item
CAS_2059_sm_FigS3.tif1267KSupporting info item
CAS_2059_sm_FigS4.tif2249KSupporting info item
CAS_2059_sm_FigS5.tif1498KSupporting info item
CAS_2059_sm_TableS1.doc32KSupporting info item
CAS_2059_sm_TableS2.doc27KSupporting info item

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.